[New strategies in the immunotherapy of autoimmune diseases].
Lorenz
H M
HM
Medizinische Klinik III, Universität Erlangen-Nürnberg. Hannes.Lorenz@med3.imed.uni-erlangen.de
Geiler
T
T
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D003424:Crohn Disease / Q000276:immunology / Q000628:therapy*; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D007167:Immunotherapy; D016032:Randomized Controlled Trials as Topic; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D016207:Cytokines; D007136:Immunoglobulins; D014409:Tumor Necrosis Factor-alpha